| dc.contributor.author | Majinda, Runner R.T. | |
| dc.contributor.author | Motswaledi, Modisa | |
| dc.contributor.author | Waigh, Roger D. | |
| dc.contributor.author | Waterman, Peter G. | |
| dc.date.accessioned | 2019-06-07T09:59:31Z | |
| dc.date.available | 2019-06-07T09:59:31Z | |
| dc.date.issued | 1997 | |
| dc.identifier.citation | Majinda, R.R.T. et al. (1997) Phenolic and antibacterial constituents of Vahlia capensis. Planta Medica, Vol. 63, No. 3, pp. 268-270 | en_US |
| dc.identifier.issn | 0032-0943 | |
| dc.identifier.uri | http://hdl.handle.net/10311/1938 | |
| dc.description | NB: Some symbols may not appear as they are on the original document. | en_US |
| dc.description.abstract | The n-butanol fraction of Vahlia capensis yielded kaempferol, quercetin, afzelin, astragalin, quercitrin, iso-quercitrin, rutin, gallic acid, chiro-inositol, dulcitol, and a novel biflavonoid, VC-15B (vahlia biflavone). The compounds were identified using ID and 2D NMR techniques and FABMS. Vahlia biflavone and gallic acid were isolated, using bioassay-guided procedure and identified as the antibacterial components. Both compounds showed activity against Gram positive Staphylococcus aureus and Bacillus subtilis. Vahlia biflavone gave MIC values of 15.3 µg/ml and 30.6 µg/ml against S. aureus and B. subtilis, respectively while gallic acid gave a value of 71.3 µg/ml for both organisms. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Georg Thieme Verlag, https://www.thieme.com/books-main/biochemistry/product/3494-planta-medica | en_US |
| dc.title | Phenolic and antibacterial constituents of Vahlia capensis | en_US |
| dc.type | Published Article | en_US |
| dc.link | https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-2006-957671 | en_US |
